Dyfyniad APA

Vesikari, T., Finn, A., van Damme, P., Leroux-Roels, I., Leroux-Roels, G., Segall, N., . . . Group, C. S. (2021). Immunogenicity and safety of a 3-antigen hepatitis B vaccine vs a single-antigen hepatitis B vaccine: A phase 3 randomized clinical trial. American Medical Association.

Dyfyniad Arddull Chicago

Vesikari, T., et al. Immunogenicity and Safety of a 3-antigen Hepatitis B Vaccine Vs a Single-antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical Trial. American Medical Association, 2021.

Dyfyniad MLA

Vesikari, T., et al. Immunogenicity and Safety of a 3-antigen Hepatitis B Vaccine Vs a Single-antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical Trial. American Medical Association, 2021.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.